A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells – An Analysis for Patients with Incurable Pancreatic Cancer

YOSHIYUKI YAMAGUCHI; YOUSUKE KATATA; MAKOTO OKAWAKI; AKIRA SAWAKI; MASAHIRO YAMAMURA

Research ArticleClinical Studies

A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells – An Analysis for Patients with Incurable Pancreatic Cancer

YOSHIYUKI YAMAGUCHI, YOUSUKE KATATA, MAKOTO OKAWAKI, AKIRA SAWAKI and MASAHIRO YAMAMURA

Anticancer Research May 2016, 36 (5) 2307-2313;

YOSHIYUKI YAMAGUCHI

Department of Clinical Oncology, Kawasaki Medical School and Hospital, Kurashiki, Okayama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: shogo{at}med.kawasaki-m.ac.jp

YOUSUKE KATATA

Department of Clinical Oncology, Kawasaki Medical School and Hospital, Kurashiki, Okayama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MAKOTO OKAWAKI

Department of Clinical Oncology, Kawasaki Medical School and Hospital, Kurashiki, Okayama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

AKIRA SAWAKI

Department of Clinical Oncology, Kawasaki Medical School and Hospital, Kurashiki, Okayama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MASAHIRO YAMAMURA

Department of Clinical Oncology, Kawasaki Medical School and Hospital, Kurashiki, Okayama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Tables

Download figure
Open in new tab
Download powerpoint
Figure 1.
Overall survival of all patients enrolled. Survival curve was drawn by Kaplan-Meyer analysis to estimate median survival time (MST). OS, Overall survival; CI, confidence interval.
Download figure
Open in new tab
Download powerpoint
Figure 2.
Univariate regression analysis between survival and the percentage of peripheral blood lymphocytes at the beginning of ZAK cell AIT. CC, Correlation coefficient; CI, confidence interval.

Tables

Figures

PreviousNext

In this issue

Anticancer Research

Vol. 36, Issue 5

May 2016

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells – An Analysis for Patients with Incurable Pancreatic Cancer

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 2 + 4 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells – An Analysis for Patients with Incurable Pancreatic Cancer

YOSHIYUKI YAMAGUCHI, YOUSUKE KATATA, MAKOTO OKAWAKI, AKIRA SAWAKI, MASAHIRO YAMAMURA

Anticancer Research May 2016, 36 (5) 2307-2313;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells – An Analysis for Patients with Incurable Pancreatic Cancer

YOSHIYUKI YAMAGUCHI, YOUSUKE KATATA, MAKOTO OKAWAKI, AKIRA SAWAKI, MASAHIRO YAMAMURA

Anticancer Research May 2016, 36 (5) 2307-2313;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

No citing articles found.

Google Scholar

Keywords

Adoptive immunotherapy (AIT)
zoledronate
ZAK cells
γδT cells
pancreatic cancer

Main menu

User menu

Search

A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells – An Analysis for Patients with Incurable Pancreatic Cancer

Article Figures & Data

Figures

Tables

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords